Essex Biotechnology Secures Exclusive Global Rights
Essex Biotechnology Secures Exclusive Global Rights and Interests of SkQ1 in the field Ophthalmology from Mitotech
Stay updated with breaking news from Mitotech Sa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Essex Biotechnology Secures Exclusive Global Rights and Interests of SkQ1 in the field Ophthalmology from Mitotech
HONG KONG, Oct 13, 2022 - (ACN Newswire) - Essex Bio-Technology Limited (the "Company", together with its subsidiaries, the "Group") wishes to announce that Essex Bio-Investment Limited ("Essex Bio-Investment")
HONG KONG, Oct 13, 2022 - (ACN Newswire) - Essex Bio-Technology Limited (the "Company", together with its subsidiaries, the "Group") wishes to announce that Essex Bio-Investment Limited ("Essex Bio-Investment"), a wholly-owned subsidiary of the Group has on 13 October 2022 successfully secured (i) a patent and know-how licence agreement; and (ii) a patent assignment deed (together as the "Agreements") in...
Achieves an increase of 58% in Profit-After-Tax to HK$346.0 million and Turnover Growth of 67.4% to HK$1,637.7 millionHONG KONG, Mar 22, 2022 - (ACN Newswire) - Essex Bio-Technology Ltd ("Essex" or the
LUXEMBOURG, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Mitotech S.A, a Luxembourg-based clinical-stage biotechnology company, announced that its Chief Scientific...